Pharmacokinetics and Metabolism of [14C] BMS-690514 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 30 Jul 2008
At a glance
- Drugs BMS 690514 (Primary)
- Indications Breast cancer; Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 30 Jul 2008 Actual end date (Jan 2008) added as reported by ClinicalTrials.gov.
- 07 Feb 2008 New trial record.